Skip to Content

Apokyn Bertek Pharmaceuticals - Treatment for Parkinson’s Disease

Apokyn (apomorphine hydrochloride injection) is the first and only therapy in the United States for the acute, intermittent treatment of hypomobility, “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) associated with advanced Parkinson’s disease.

Posted: April 2004

Apokyn (apomorphine) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.